Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · IEX Real-Time Price · USD
3.780
+0.060 (1.61%)
Jul 22, 2024, 9:30 AM EDT - Market open
Akari Therapeutics, Employees
As of December 31, 2023, Akari Therapeutics, had 12 total employees, including 9 full-time and 3 part-time employees. The number of employees decreased by 3 or -20.00% compared to the previous year.
Employees
12
Change (1Y)
-3
Growth (1Y)
-20.00%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
29.95M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Rapid Micro Biosystems | 193 |
Pluri | 134 |
Bolt Biotherapeutics | 100 |
Enlivex Therapeutics | 71 |
Surrozen | 42 |
Palatin Technologies | 34 |
Daré Bioscience | 26 |
bioAffinity Technologies | 14 |
AKTX News
- 2 months ago - Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights - GlobeNewsWire
- 2 months ago - Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics - GlobeNewsWire
- 2 months ago - Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity - GlobeNewsWire
- 3 months ago - Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024 - GlobeNewsWire
- 4 months ago - Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights - GlobeNewsWire
- 4 months ago - AKTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Akari Therapeutics, Plc Is Fair to Shareholders - Business Wire
- 4 months ago - Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit - GlobeNewsWire
- 7 months ago - Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing - GlobeNewsWire